RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Psycheceutical Bioscience Stocks 2024

Psycheceutical Bioscience Stocks

225.26 M

Psycheceutical Bioscience Dividend yield

Ticker

BWVI

ISIN

US09609E1055

In 2024, Psycheceutical Bioscience had 225.26 M outstanding stocks, a 205.95% change from the 73.63 M stocks in the previous year.

The Psycheceutical Bioscience Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2022225.26
202173.63
20111.29
20101.29
20091.29
20081.1
20071
20060.28
20050.25
20040.23
20030.2

Psycheceutical Bioscience Aktienanalyse

What does Psycheceutical Bioscience do?

Blue Water Ventures International Inc (BWVI) is a company specialized in the exploration of treasures on the seabed. The company's history dates back to 2005 when founder Keith Webb had the idea to search for lost treasures at sea. Since then, BWVI has become a leading company in the industry. BWVI's business model is based on treasure hunting at sea. The company uses state-of-the-art technologies to locate shipwrecks and other treasures on the ocean floor. Once a treasure is discovered, BWVI forms partnerships with other companies to recover and market the treasure. The profits from the sale of the treasure are divided between BWVI and its partners. BWVI also owns and operates its own online auction where antiques such as jewelry, historical coins, and artifacts are exhibited and sold. The auction is an important part of BWVI's business model and offers customers the opportunity to acquire unique treasures. The company has various divisions all focused on underwater treasure hunting. One division focuses on the exploration and search for sunken ships and artifacts. Another division focuses on the exploration of sites where potential treasures are suspected. BWVI utilizes state-of-the-art technologies such as sonar and magnetic sensors to locate underwater treasures. BWVI also offers services such as archiving and restoration of artifacts. The company collaborates with experts to ensure the best possible preservation and restoration of historical artifacts. BWVI's portfolio includes a variety of products and services. These include unique treasures such as jewels, gold and silver coins, ceramics, and other artifacts recovered from historical shipwrecks. Additionally, the company also offers merchandising items such as t-shirts, caps, and keychains featuring the BWVI logo. Recently, BWVI has also begun to explore other business areas. The company has partnered with a CBD product manufacturer and will be bringing CBD products to the market. Furthermore, BWVI has plans to enter the field of renewable energies, particularly tidal power plants. Overall, BWVI has undergone an impressive development in recent years. The company has established itself as a leading player in underwater treasure hunting and offers its customers a unique experience. With a strong portfolio of products and services and a clear vision for the future, BWVI is well-positioned to continue its success in the future. Psycheceutical Bioscience ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Psycheceutical Bioscience's Shares Outstanding

Psycheceutical Bioscience's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Psycheceutical Bioscience’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Psycheceutical Bioscience’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Psycheceutical Bioscience’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Psycheceutical Bioscience Stock

How many stocks are there of Psycheceutical Bioscience?

The current number of stocks of Psycheceutical Bioscience is 225.26 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Psycheceutical Bioscience are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Psycheceutical Bioscience evolved in recent years?

The number of shares of Psycheceutical Bioscience has increased by 205.95% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Psycheceutical Bioscience as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Psycheceutical Bioscience?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Psycheceutical Bioscience pay?

Over the past 12 months, Psycheceutical Bioscience paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Psycheceutical Bioscience is expected to pay a dividend of 0 USD.

What is the dividend yield of Psycheceutical Bioscience?

The current dividend yield of Psycheceutical Bioscience is .

When does Psycheceutical Bioscience pay dividends?

Psycheceutical Bioscience pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Psycheceutical Bioscience?

Psycheceutical Bioscience paid dividends every year for the past 0 years.

What is the dividend of Psycheceutical Bioscience?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Psycheceutical Bioscience located?

Psycheceutical Bioscience is assigned to the '-' sector.

Wann musste ich die Aktien von Psycheceutical Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Psycheceutical Bioscience from 6/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/2/2024.

When did Psycheceutical Bioscience pay the last dividend?

The last dividend was paid out on 6/2/2024.

What was the dividend of Psycheceutical Bioscience in the year 2023?

In the year 2023, Psycheceutical Bioscience distributed 0 USD as dividends.

In which currency does Psycheceutical Bioscience pay out the dividend?

The dividends of Psycheceutical Bioscience are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Psycheceutical Bioscience

Our stock analysis for Psycheceutical Bioscience Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Psycheceutical Bioscience Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.